OBJECTIVES: The purpose of this study was to correlate 2-dimensional magnetic resonance (MR) measurements of lateral ventricular width and 3-dimensional measurements of lateral ventricular and supratentorial parenchymal volumes to postnatal outcomes in fetuses with ventriculomegaly. METHODS: A total of 307 fetuses (mean gestational age, 26.0 weeks; range, 15.7-39.4 weeks) had MR volumetry after referral for ventriculomegaly. Fetuses were grouped into those with (n = 114) and without (n = 193) other central nervous system (CNS) anomalies. Pregnancy and postnatal neurodevelopmental outcomes up to 3 years of age were obtained. A subgroup analysis was performed excluding fetuses with other CNS anomalies. Logistic regression analysis was performed to assess which measurement was most predictive of outcomes. RESULTS: There were 50 terminations, 2 stillbirths, and 255 live births. Seventy-five cases were lost to follow-up. Among 180 live-born neonates with follow-up, 140 had abnormal and 40 had normal outcomes. Atrial diameter (P < .0001), frontal horn diameter (P < .0001), and ventricular volume (P = .04) were predictive of live birth, with 92% specificity at 60% sensitivity. Among fetuses without other CNS anomalies, 180 of 193 pregnancies (93%) resulted in live deliveries, with atrial diameter (P < .0001), frontal horn diameter (P = .003), and ventricular volume (P = .008) associated with live birth and atrial diameter having the highest specificity (>99% at 60% sensitivity). Parenchymal volume was not associated with normal or abnormal outcomes (either live birth versus death or normal versus abnormal neurodevelopmental outcome). Among live-born neonates, no age-adjusted threshold for any of the measurements reliably distinguished between normal and abnormal neurodevelopmental outcomes. CONCLUSIONS: Ventricular volume and diameter, but not parenchymal volume, correlate with live birth in fetuses with ventriculomegaly. However, once live born, neither 2- nor 3-dimensional measurements can distinguish a fetus that will have a normal outcome.
OBJECTIVES: The purpose of this study was to correlate 2-dimensional magnetic resonance (MR) measurements of lateral ventricular width and 3-dimensional measurements of lateral ventricular and supratentorial parenchymal volumes to postnatal outcomes in fetuses with ventriculomegaly. METHODS: A total of 307 fetuses (mean gestational age, 26.0 weeks; range, 15.7-39.4 weeks) had MR volumetry after referral for ventriculomegaly. Fetuses were grouped into those with (n = 114) and without (n = 193) other central nervous system (CNS) anomalies. Pregnancy and postnatal neurodevelopmental outcomes up to 3 years of age were obtained. A subgroup analysis was performed excluding fetuses with other CNS anomalies. Logistic regression analysis was performed to assess which measurement was most predictive of outcomes. RESULTS: There were 50 terminations, 2 stillbirths, and 255 live births. Seventy-five cases were lost to follow-up. Among 180 live-born neonates with follow-up, 140 had abnormal and 40 had normal outcomes. Atrial diameter (P < .0001), frontal horn diameter (P < .0001), and ventricular volume (P = .04) were predictive of live birth, with 92% specificity at 60% sensitivity. Among fetuses without other CNS anomalies, 180 of 193 pregnancies (93%) resulted in live deliveries, with atrial diameter (P < .0001), frontal horn diameter (P = .003), and ventricular volume (P = .008) associated with live birth and atrial diameter having the highest specificity (>99% at 60% sensitivity). Parenchymal volume was not associated with normal or abnormal outcomes (either live birth versus death or normal versus abnormal neurodevelopmental outcome). Among live-born neonates, no age-adjusted threshold for any of the measurements reliably distinguished between normal and abnormal neurodevelopmental outcomes. CONCLUSIONS: Ventricular volume and diameter, but not parenchymal volume, correlate with live birth in fetuses with ventriculomegaly. However, once live born, neither 2- nor 3-dimensional measurements can distinguish a fetus that will have a normal outcome.
Authors: M Beeghly; J Ware; J Soul; A du Plessis; O Khwaja; G M Senapati; C D Robson; R L Robertson; T Y Poussaint; C E Barnewolt; H A Feldman; J A Estroff; D Levine Journal: Ultrasound Obstet Gynecol Date: 2010-04 Impact factor: 7.299
Authors: D H Pretorius; K Davis; M L Manco-Johnson; D Manchester; P R Meier; W H Clewell Journal: AJR Am J Roentgenol Date: 1985-04 Impact factor: 3.959
Authors: Y Li; J A Estroff; O Khwaja; T S Mehta; T Y Poussaint; C D Robson; H A Feldman; J Ware; D Levine Journal: Ultrasound Obstet Gynecol Date: 2012-11 Impact factor: 7.299
Authors: Lindsay B Kilburn; Mehmet Kocak; Patricia Baxter; Tina Young Poussaint; Arnold C Paulino; Christine McIntyre; Annabelle Lemenuel-Diot; Christine Lopez-Diaz; Larry Kun; Murali Chintagumpala; Jack M Su; Alberto Broniscer; Justin N Baker; Eugene I Hwang; Maryam Fouladi; James M Boyett; Susan M Blaney Journal: Pediatr Blood Cancer Date: 2017-11-01 Impact factor: 3.167
Authors: Jared M Pisapia; Saurabh Sinha; Deborah M Zarnow; Mark P Johnson; Gregory G Heuer Journal: Childs Nerv Syst Date: 2017-05-16 Impact factor: 1.475
Authors: G Lockwood Estrin; V Kyriakopoulou; A Makropoulos; G Ball; L Kuhendran; A Chew; B Hagberg; M Martinez-Biarge; J Allsop; M Fox; S J Counsell; M A Rutherford Journal: Neuroimage Clin Date: 2016-01-14 Impact factor: 4.881